UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

2014 Final analysis of the PEAK trial: Overall survival (OS) and tumour responses during first-line treatment with mFOLFOX6 + either panitumumab (pmab) or bevacizumab (bev) in patients (pts) with metastatic colorectal carcinoma (mCRC)

European journal of cancer (1990), 2015-09, Vol.51, p.S332-S333

2015

Volltextzugriff (PDF)

1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC)

European journal of cancer (1990), 2015-09, Vol.51, p.S287-S288

2015

Volltextzugriff (PDF)

194 A Phase II Study of Trastuzumab Plus Capecitabine with or Without Pertuzumab for HER2-positive Metastatic Breast Cancer as Second-line Treatment (PHEREXA)

European journal of cancer (1990), 2012-03, Vol.48, p.S97-S97

2012

Volltextzugriff (PDF)

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

Annals of oncology, 2014-07, Vol.25 (7), p.1346-1355

2014

Volltextzugriff (PDF)

Agrobacterium radiobacter bacteremia in oncologic and geriatric patients: presentation of two cases and review of the literature

International journal of infectious diseases, 2008-11, Vol.12 (6), p.e7-e10

2008

Volltextzugriff (PDF)

TRASTUZUMAB TREATMENT OF EARLY STAGE BREAST CANCER IS COST-EFFECTIVE FROM THE PERSPECTIVE OF THE BELGIAN HEALTH CARE AUTHORITIES

Acta clinica belgica (English ed. Online), 2009-04, Vol.64 (2), p.100-112

2009

Volltextzugriff (PDF)

450 A Belgian multicenter phase II randomized trial in HER2-negative metastatic breast cancer evaluating consolidation antiangiogenic therapy with sunitinib after objective response to taxane-based chemotherapy

European journal of cancer supplements, 2010, Vol.8 (3), p.190-190

2010

Volltextzugriff (PDF)

131P Efficacy of neoadjuvant letrozole and palbociclib in HER2-low vs HER2 zero luminal breast cancer: An analysis of the Unicancer Neopal phase II study

ESMO open, 2023-05, Vol.8 (1), p.101470, Article 101470

2023

Volltextzugriff (PDF)

5075 Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+ advanced breast cancer

European journal of cancer supplements, 2009, Vol.7 (2), p.283-283

2009

Volltextzugriff (PDF)

Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial

Annals of oncology, 2012-07, Vol.23 (7), p.1780-1788

2012

Volltextzugriff (PDF)

Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer

Breast cancer research and treatment, 2010-09, Vol.123 (2), p.463-469

2010

Volltextzugriff (PDF)

High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008)

Supportive care in cancer, 2012, Vol.20 (1), p.23-28

2012

Volltextzugriff (PDF)

Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study

Gynecologic oncology, 2003-10, Vol.91 (1), p.32-38

2003

Volltextzugriff (PDF)

Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature

Acta clinica belgica (English ed. Online), 2004-07, Vol.59 (4), p.220-222

2004

Volltextzugriff (PDF)

Sequential Administration of Epirubicin and Paclitaxel for Advanced Breast Cancer. A Phase I Randomised Trial

Anticancer research, 2005-03, Vol.25 (2B), p.1211-1217

2005

Volltextzugriff (PDF)

95 Concomitant high-dose chemotherapy (HDCt) and radiotherapy (Rt) with G-CSF and peripheral blood stem cell (PBSC) rescue for limited (LD) small cell lung cancer (SCLC)

Lung cancer (Amsterdam, Netherlands), 1997-08, Vol.18, p.27-27

1997

Volltextzugriff (PDF)

SACCHAROMYCES CEREVISIAE FUNGEMIA IN A HEAD AND NECK CANCER PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE

Acta Clinica Belgica, 2004, Vol.59 (4), p.220-222

2004

Volltextzugriff (PDF)

Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature

Acta clinica belgica (English ed. Online), 1991, Vol.46 (3), p.178-182

1991

Volltextzugriff (PDF)

Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan: A case report with pulmonary manifestations and review of the literature

Acta Clinica Belgica, 1991, Vol.46 (3), p.178-182

1991

Volltextzugriff (PDF)

Association of genes involved in carcass and meat quality traits in 15 European bovine breeds

Livestock science, 2013-06, Vol.154 (1-3), p.34-44

2013

Volltextzugriff (PDF)

Muscle lipid composition in bulls from 15 European breeds

Livestock science, 2014-02, Vol.160, p.1-11

2014

Volltextzugriff (PDF)

PD-0885 Quality of Life improvement in patients with bone metastases undergoing palliative radiotherapy

Radiotherapy and oncology, 2021-08, Vol.161, p.S722-S723

2021

Volltextzugriff (PDF)

Polymorphisms in twelve candidate genes are associated with growth, muscle lipid profile and meat quality traits in eleven European cattle breeds

Molecular biology reports, 2014-07, Vol.41 (7), p.4721-4731

2014

Volltextzugriff (PDF)

Estimation of the genetic admixture composition of Iberian dry-cured ham samples using DNA multilocus genotypes

Meat science, 2006-03, Vol.72 (3), p.560-566

2006

Volltextzugriff (PDF)

Estudio epidemiológico observacional prospectivo del manejo del dolor en pacientes oncológicos en tratamiento radioterápico: estudio GORVAMUR

Revista de la Sociedad Española del Dolor, 2017-10, Vol.24 (5), p.241-255

2017

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Female
(11)
Humans
(11)
Biological And Medical Sciences
(8)
Aged
(7)
Medical Sciences
(7)
Middle Aged
(7)
Oncology
(7)
Adult
(6)
Cancer
(6)
Agriculture
(5)
Agriculture, Dairy & Animal Science
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Chemotherapy
(5)
Hematology, Oncology And Palliative Medicine
(5)
Male
(5)
Tumors
(5)
Animals
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2014 Final analysis of the PEAK trial: Overall survival (OS) and tumour responses during first-line treatment with mFOLFOX6 + either panitumumab (pmab) or bevacizumab (bev) in patients (pts) with metastatic colorectal carcinoma (mCRC)

1866 First results from the double-blind placebo (PL)-controlled randomised phase III MERiDiAN trial prospectively evaluating plasma (p)VEGF-A in patients (pts) receiving first-line paclitaxel (PAC) +/- bevacizumab (BV) for HER2-negative metastatic breast cancer (mBC)

194 A Phase II Study of Trastuzumab Plus Capecitabine with or Without Pertuzumab for HER2-positive Metastatic Breast Cancer as Second-line Treatment (PHEREXA)

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

Agrobacterium radiobacter bacteremia in oncologic and geriatric patients: presentation of two cases and review of the literature

TRASTUZUMAB TREATMENT OF EARLY STAGE BREAST CANCER IS COST-EFFECTIVE FROM THE PERSPECTIVE OF THE BELGIAN HEALTH CARE AUTHORITIES

450 A Belgian multicenter phase II randomized trial in HER2-negative metastatic breast cancer evaluating consolidation antiangiogenic therapy with sunitinib after objective response to taxane-based chemotherapy

131P Efficacy of neoadjuvant letrozole and palbociclib in HER2-low vs HER2 zero luminal breast cancer: An analysis of the Unicancer Neopal phase II study

5075 Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+ advanced breast cancer

Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial

Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer

High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008)

Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study

Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature

Sequential Administration of Epirubicin and Paclitaxel for Advanced Breast Cancer. A Phase I Randomised Trial

95 Concomitant high-dose chemotherapy (HDCt) and radiotherapy (Rt) with G-CSF and peripheral blood stem cell (PBSC) rescue for limited (LD) small cell lung cancer (SCLC)

SACCHAROMYCES CEREVISIAE FUNGEMIA IN A HEAD AND NECK CANCER PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE

Eosinophilia-myalgia syndrome associated with L-tryptophan. A case report with pulmonary manifestations and review of the literature

Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan: A case report with pulmonary manifestations and review of the literature

Association of genes involved in carcass and meat quality traits in 15 European bovine breeds

Muscle lipid composition in bulls from 15 European breeds

PD-0885 Quality of Life improvement in patients with bone metastases undergoing palliative radiotherapy

Polymorphisms in twelve candidate genes are associated with growth, muscle lipid profile and meat quality traits in eleven European cattle breeds

Estimation of the genetic admixture composition of Iberian dry-cured ham samples using DNA multilocus genotypes

Estudio epidemiológico observacional prospectivo del manejo del dolor en pacientes oncológicos en tratamiento radioterápico: estudio GORVAMUR

Suchergebnisse filtern